Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

21 Jul 2022 07:00

RNS Number : 2077T
Diploma PLC
21 July 2022
 

 

DIPLOMA PLC

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

 

 

21 JULY 2022

 

DIPLOMA PLC

STRONG Q3 PERFORMANCE, CONFIDENT IN FULL YEAR GUIDANCE

 

Diploma PLC, the international group distributing specialised products and services, today issues a trading update for the nine months ended 30 June 2022.

Year to date performance

Performance in the third quarter has remained strong with organic growth of 13%. We continue to focus on revenue diversification activity to drive growth, build scale and increase resilience. We drive this diversification by positioning behind structurally growing end markets, further penetrating core developed economies and extending product ranges to expand addressable markets.

During the first nine months of FY 2022:

·

Organic revenue growth was 15% driven by our organic revenue initiatives, continuing positive demand and pricing:

o Controls: acceleration at International Controls and continued strong volume growth at Windy City Wire.

o Seals: sustained market share gains in North American Aftermarket and broad-based growth at International Seals against a robust comparator.

o Life Sciences: as expected, impacted by one-off COVID-related revenues in the prior year. Remain confident in a return to growth during H2.

·

The impact of the pass through of higher copper prices has moderated during Q3 against a higher comparator, contributing ca. 3% to organic growth in the year to date.

·

Reported revenue growth was 26%, reflecting a positive contribution from high quality acquisitions and a ca. 2% foreign exchange tailwind

·

Strategically important acquisitions completed in Q3 will accelerate future organic growth in key business lines:

o R&G Fluid Power Group: successfully delivering on its organic and inorganic growth strategy, including two small bolt-on acquisitions for a total consideration of ca. £4 million.

o Accuscience: exciting prospects, particularly in the high growth diagnostics segment.

·

We remain disciplined in our approach to acquisitions and our pipeline is encouraging.

·

Our operating margin performance continues to be strong, demonstrating the power of our value-added service model which drives customer loyalty and pricing power. We continue to successfully manage supply chain pressures, tight labour markets and inflation.

Full year outlook positive and unchanged

The Group's performance in the first nine months of FY 2022 means we are confident in delivering our full year guidance:

·

Low double digit organic revenue growth.

·

Reported revenue growth a little over 20%.

·

Operating margin at the top end of the 18-19% guidance range.

·

Strong cash generation currently expected to result in net debt/EBITDA of ca. 1.5x by year end. 

 

Whilst the wider macroeconomic outlook is uncertain, the Group's resilience is supported by our increasing revenue diversification, our value-added model, and strong cash generation and balance sheet. We remain focused on executing our strategy of building high-quality, scalable businesses for organic growth and are confident in our long-term prospects.

Our next scheduled update will be the publication of our full year results on 21 November 2022.

 

Johnny Thomson, Chief Executive Officer, and Barbara Gibbes, Chief Financial Officer, will host a conference call for analysts and investors this morning at 8:30am (UK time). Conference call dial in details:

· Dial in: +44 (0)330 165 4012

· Participant access code: 6981796

 

A recording of the call will be made available on the website later in the day or can be requested by contacting investors@diplomaplc.com

 

Enquiries:

Diploma PLC

+44 (0)20 7549 5700

Johnny Thomson, Chief Executive Officer

Barbara Gibbes, Chief Financial Officer

Kellie McAvoy, Head of Investor Relations

Tulchan Communications

+44 (0)20 7353 4200

Martin Robinson

Olivia Peters

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

 

Notes:

 

1. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of Diploma PLC. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. Diploma PLC uses alternative performance measures as key financial indicators to assess the organic performance of the Group. All references in this Statement to "organic" revenues refer to reported results on a constant currency basis, before acquired or disposed businesses (ex-growth basis) and include growth generated by acquisitions under our ownership.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUBAMUPPGQU
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.